Ritalin SR Methylphenidate SR 20 mg


Price : Call for best offers

Ritalin SR is a brand name that contains Methylphenidate in it. This medical content is treating signs and symptoms of ADHD – Attention Deficit Hyperactivity Disorder. Methylphenidate belongs to a class of drugs known as CNS stimulants. It helps to increase attention and decrease restlessness in children and adults who have been diagnosed with ADHD. Ritalin presumably activates the brain stem arousal system and cortex to produce its stimulant effect. Psychological, educational, and social therapies are used along with methylphenidate as part of an overall treatment program for ADHD. This medication also helps to stimulate people with narcolepsy so that they do not fall asleep at inappropriate times.

Add To Cart
The sustain release version of Methylphenidate is more slowly but as extensively absorbed as in the regular tablets. In a general dose of Ritalin SR tablet, there is a white to the off-white, round, biconvex, beveled edge, film-coated tablet, containing 20 mg of methylphenidate that imprinted with CIBA on one side and 16 on the other side in black ink. Doses above 60 mg daily are not recommended. The medical professional should inform about the side effects like increased heart rate, blood pressure, slurred speech, feeling more excitement, numbness, slurred speech, Slowed growth (height and weight) in children, etc.
Ritalin SR is indicated in the treatment of Attention-Deficit/Hyperactivity Disorder in children aged 6 years or older. Ritalin is indicated as part of a comprehensive treatment program that typically includes psychological, educational, and social measures and is aimed at stabilizing children with a behavioral syndrome characterized by moderate to severe distractibility, short attention span, hyperactivity, emotional ability, and impulsivity.
Ritalin is contraindicated also in patients known to be hypersensitive to the drug, in patients with glaucoma, and in patients with motor tics or with a family history or diagnosis of Tourette’s syndrome. Ritalin is contraindicated during treatment with monoamine oxidase inhibitors, and also within a minimum of 14 days following discontinuation of a monoamine oxidase inhibitor (hypertensive crises may result).

Related Products